|
|
||||||||
1


*
Division of General Internal Medicine, Department of Medicine and
Department of Nuclear Medicine, University Hospital Nijmegen, Nijmegen, The Netherlands; and
Department of Medicine, Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, CO 80261
IL-1
and IL-1ß are proinflammatory cytokines involved
in the pathogenesis of many infectious and noninfectious inflammatory
diseases. To reduce IL-1 toxicity, extracellular domains of the soluble
(s) IL-1R are shed from cell membranes and prevent triggering of
cell-bound receptors. We investigated to what extent murine sIL-1RI can
neutralize the IL-1 produced by LPS-stimulated macrophages. When mouse
peritoneal macrophages were incubated with LPS, addition of sIL-1RI
significantly inhibited the bioactivity of IL-1. Stimulation of cells
with sIL-1RI alone induced no bioactive IL-1. When immunoreactive
cytokine concentrations were measured with specific radioimmunoassays,
sIL-1RI alone appeared to induce a significant release of IL-1
in a
concentration-dependent manner. This effect was independent of new
protein synthesis. The production of IL-1ß or TNF-
was not
influenced by sIL-1RI. There was no interference of sIL-1RI with the
IL-1
radioimmunoassay. In mice, an i.v. injection of sIL-RI alone
induced a rapid release of IL-1
, but not of TNF-
or IL-1ß.
Treatment of mice with sIL-1RI improved the survival during a lethal
infection with Candida albicans. In conclusion, sIL-1RI
induces a rapid release of IL-1
from cells, as well as into the
systemic circulation. Although this IL-1
may be inactivated in
circulation by the same sIL-1RI, this phenomenon probably has
immunostimulatory effects at local levels where the sIL-1RI-induced
IL-1
acts in a paracrine or autocrine manner.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |